BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 17890276)

  • 21. Features of 847 Childhood-Onset Systemic Lupus Erythematosus Patients in Three Age Groups at Diagnosis: A Brazilian Multicenter Study.
    Gomes RC; Silva MF; Kozu K; Bonfá E; Pereira RM; Terreri MT; Magalhães CS; Sacchetti SB; Marini R; Fraga M; Carvalho LM; Barbosa CM; Carneiro-Sampaio M; Silva CA
    Arthritis Care Res (Hoboken); 2016 Nov; 68(11):1736-1741. PubMed ID: 27014968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyper IgM syndrome and complement Clq deficiency in an individual with systemic lupus erythematosus-like disease.
    Tsuge I; Kondo Y; Nakajima Y; Nakagawa N; Imai K; Nonoyama S; Oshima K; Ohara O; Hatanaka M; Kitano E; Kitamura H; Urisu A
    Clin Exp Rheumatol; 2010; 28(4):558-60. PubMed ID: 20810037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-C1q autoantibodies.
    Kallenberg CG
    Autoimmun Rev; 2008 Sep; 7(8):612-5. PubMed ID: 18606253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations.
    Magalhães MB; da Silva LM; Voltarelli JC; Donadi EA; Louzada-Junior P
    Scand J Rheumatol; 2007; 36(6):442-7. PubMed ID: 18092265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Homozygosity for a novel mutation in the C1q C chain gene in a Turkish family with hereditary C1q deficiency.
    Gulez N; Genel F; Atlihan F; Gullstrand B; Skattum L; Schejbel L; Garred P; Truedsson L
    J Investig Allergol Clin Immunol; 2010; 20(3):255-8. PubMed ID: 20635792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of occurrence of severe lupus nephritis among anti-C1q autoantibody-negative patients.
    Trendelenburg M; Marfurt J; Gerber I; Tyndall A; Schifferli JA
    Arthritis Rheum; 1999 Jan; 42(1):187-8. PubMed ID: 9920031
    [No Abstract]   [Full Text] [Related]  

  • 27. Hereditary complement deficiency and lupus: report of four Tunisian cases.
    Kallel-Sellami M; Baili-Klila L; Zerzeri Y; Laadhar L; Blouin J; Abdelmalek R; Fremeaux-Bacchi V; Zitouni M; Makni S
    Ann N Y Acad Sci; 2007 Jun; 1108():197-202. PubMed ID: 17893986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic lupus erythematosus with C1q deficiency.
    Stone NM; Williams A; Wilkinson JD; Bird G
    Br J Dermatol; 2000 Mar; 142(3):521-4. PubMed ID: 10735963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Infantile case of early manifestation of SLE-like symptoms in complete C1q deficiency.
    Hayakawa J; Migita M; Ueda T; Itoh Y; Fukunaga Y
    J Nippon Med Sch; 2011; 78(5):322-8. PubMed ID: 22041880
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Marked variability in clinical presentation and outcome of patients with C1q immunodeficiency.
    van Schaarenburg RA; Schejbel L; Truedsson L; Topaloglu R; Al-Mayouf SM; Riordan A; Simon A; Kallel-Sellami M; Arkwright PD; Åhlin A; Hagelberg S; Nielsen S; Shayesteh A; Morales A; Tam S; Genel F; Berg S; Ketel AG; Merlijn van den Berg J; Kuijpers TW; Olsson RF; Huizinga TW; Lankester AC; Trouw LA
    J Autoimmun; 2015 Aug; 62():39-44. PubMed ID: 26119135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinicopathological conference: an 11-year-old boy with recurrent infections, hypertension, skin rash, and nephritic syndrome.
    Tinaztepe K; Güçer S; Bakkaloğlu A
    Turk J Pediatr; 2000; 42(4):312-8. PubMed ID: 11196749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinicopathologic profile of normocomplementemic and hypocomplementemic urticarial vasculitis: a study from South India.
    Dincy CV; George R; Jacob M; Mathai E; Pulimood S; Eapen EP
    J Eur Acad Dermatol Venereol; 2008 Jul; 22(7):789-94. PubMed ID: 18331318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. C1q inhibits immune complex-induced interferon-alpha production in plasmacytoid dendritic cells: a novel link between C1q deficiency and systemic lupus erythematosus pathogenesis.
    Lood C; Gullstrand B; Truedsson L; Olin AI; Alm GV; Rönnblom L; Sturfelt G; Eloranta ML; Bengtsson AA
    Arthritis Rheum; 2009 Oct; 60(10):3081-90. PubMed ID: 19790049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Longterm clinical and immunological effects of anti-CD20 treatment in patients with refractory systemic lupus erythematosus.
    Lindholm C; Börjesson-Asp K; Zendjanchi K; Sundqvist AC; Tarkowski A; Bokarewa M
    J Rheumatol; 2008 May; 35(5):826-33. PubMed ID: 18398943
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C1q deficiency in an Inuit family: identification of a new class of C1q disease-causing mutations.
    Marquart HV; Schejbel L; Sjoholm A; Martensson U; Nielsen S; Koch A; Svejgaard A; Garred P
    Clin Immunol; 2007 Jul; 124(1):33-40. PubMed ID: 17513176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pediatric systemic lupus erythematosus with C1q deficiency.
    Kallel-Sellami M; Baili-Klila L; Zerzeri Y; Laadhar L; Blouin J; Abdelmoula MS; Zitouni M; Fremeaux-Bacchi V; Ben Dridi MF; Makni S
    Ann N Y Acad Sci; 2007 Jun; 1108():193-6. PubMed ID: 17893985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. B cell depletion therapy in systemic lupus erythematosus: relationships among serum B lymphocyte stimulator levels, autoantibody profile and clinical response.
    Cambridge G; Isenberg DA; Edwards JC; Leandro MJ; Migone TS; Teodorescu M; Stohl W
    Ann Rheum Dis; 2008 Jul; 67(7):1011-6. PubMed ID: 17962238
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antineuronal antibodies and electroneurophysiological studies in pediatric patients with neuropsychiatric systemic lupus erythematosus.
    Mostafa GA; Nazif HK; El-Shahawi HH; Abd El-Aziz MM; Hassan MA
    Pediatr Allergy Immunol; 2009 Mar; 20(2):192-9. PubMed ID: 18422890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of C1q polymorphisms suggests association with systemic lupus erythematosus, serum C1q and CH50 levels and disease severity.
    Martens HA; Zuurman MW; de Lange AH; Nolte IM; van der Steege G; Navis GJ; Kallenberg CG; Seelen MA; Bijl M
    Ann Rheum Dis; 2009 May; 68(5):715-20. PubMed ID: 18504288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiphospholipid syndrome and systemic lupus erythematosus: are they separate entities or just clinical presentations on the same scale?
    Shoenfeld Y; Meroni PL; Toubi E
    Curr Opin Rheumatol; 2009 Sep; 21(5):495-500. PubMed ID: 19593144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.